American Health Packaging buprenorphine recalled for label mix-up
American Health Packaging distributed buprenorphine sublingual tablets with incorrect labeling. The affected medication is a prescription opioid used to treat pain and opioid use disorder. A label mix-up could result in dosing errors if patients or healthcare providers rely on incorrect information.
From the FDA notice · Read the official notice ↗ · All American Health Packaging recalls
What to do
- Check if your buprenorphine matches Lot #1030023 with expiration date 06/30/2027 and NDC #60687-481-21.
- Do not use affected tablets without speaking to your pharmacist or doctor first.
- Contact your pharmacy or healthcare provider for guidance on obtaining correctly labeled medication.
- Do not stop taking buprenorphine abruptly without medical supervision.
Is yours affected?
Compare your label or packaging with the recalled product.
- Product
- Buprenorphine Sublingual Tablets (C-III), 2 mg, 30 Tablets (3x10), Rx only, Distributed by: American Health Packaging, Columbus, Ohio 43217, Carton NDC#: 60687-481-21, (Individual Dose NDC: 60687-481-11).
- Sold in
- Nationwide
- Made for
- Adults
Details
- Units affected
- 10,953 cartons.
- Illnesses reported
- None reported
- Manufactured in
- 2550 John Glenn Ave Ste A, N/A, Columbus, OH, United States
- Classification
- Class III
- Recall number
- D-0840-2026
In the FDA's words
- Description
- Buprenorphine Sublingual Tablets (C-III), 2 mg, 30 Tablets (3x10), Rx only, Distributed by: American Health Packaging, Columbus, Ohio 43217, Carton NDC#: 60687-481-21, (Individual Dose NDC: 60687-481-11). Labeling: Label Mix-up Lot # 1030023, Exp Date: 06/30/2027. Distribution: US Nationwide. Affected quantity: 10,953 cartons.
- Hazard
- Labeling: Label Mix-up
More from American Health Packaging
See all- American Health Packaging cyanocobalamin recalled for possible glass
ModerateFDANov 5, 2026